4 November 2024
Spire
Healthcare Group plc
Transaction in own shares
Spire Healthcare Group plc (the
"Company") announces that, in accordance with the terms of its
share buyback programme announced on 31 October 2024 (the "Share
Buyback Programme") and the authority granted by its shareholders
at the Company's 2024 Annual General Meeting held on 9 May 2024, it
has purchased the following number of its ordinary shares of 1
pence each ("Shares") on the London Stock Exchange through Numis
Securities Limited ("Deutsche Numis"):
|
Date of purchase:
|
1 November 2024
|
|
Number of Shares purchased:
|
50,000
|
|
Highest price paid per Share (GBp):
|
220.50
|
|
Lowest price paid per Share (GBp):
|
215.75
|
|
Volume weighted average price paid per Share
(GBp):
|
217.6636
|
|
Broker:
|
Deutsche Numis
|
|
Trading venue:
|
London Stock Exchange
|
The purchased Shares will be
cancelled.
Following the purchase of these
Shares, the remaining number of Shares in issue will be
404,088,352. The Company does not hold any Shares in treasury.
Therefore, the total number of voting rights in the Company is
404,088,352. This figure may be used by shareholders as the
denominator for the calculation by which they can determine if they
are required to notify their interest in, or a change to their
interest in, the Company under the FCA's Disclosure Guidance and
Transparency Rules.
In accordance with Article 5(1)(b)
of Regulation (EU) No 596/2014 as it forms part of domestic law of
the United Kingdom by virtue of the European Union (Withdrawal) Act
2018, the table below contains detailed information of the
individual trades made by Deutsche Numis as part of the Share
Buyback Programme:
|
Date of purchase
|
Number of ordinary shares
purchased
|
Transaction price (GBp
share)
|
Time of transaction (UK
Time)
|
Transaction reference
number
|
Trading venue
|
|
1 November 2024
|
115
|
216.00
|
09:37:09
|
00072180336TRLO0
|
XLON
|
|
1 November 2024
|
357
|
216.00
|
09:37:09
|
00072180335TRLO0
|
XLON
|
|
1 November 2024
|
399
|
216.00
|
09:37:47
|
00072180342TRLO0
|
XLON
|
|
1 November 2024
|
46
|
216.00
|
09:37:47
|
00072180343TRLO0
|
XLON
|
|
1 November 2024
|
20000
|
215.75
|
09:37:55
|
00072180346TRLO0
|
XLON
|
|
1 November 2024
|
2097
|
216.50
|
10:36:03
|
00072182443TRLO0
|
XLON
|
|
1 November 2024
|
1789
|
218.50
|
10:46:46
|
00072182919TRLO0
|
XLON
|
|
1 November 2024
|
277
|
218.50
|
10:46:46
|
00072182920TRLO0
|
XLON
|
|
1 November 2024
|
277
|
218.50
|
10:46:46
|
00072182921TRLO0
|
XLON
|
|
1 November 2024
|
1800
|
218.50
|
10:46:46
|
00072182922TRLO0
|
XLON
|
|
1 November 2024
|
371
|
218.50
|
10:46:46
|
00072182923TRLO0
|
XLON
|
|
1 November 2024
|
452
|
219.00
|
10:52:57
|
00072183052TRLO0
|
XLON
|
|
1 November 2024
|
218
|
219.00
|
10:52:57
|
00072183053TRLO0
|
XLON
|
|
1 November 2024
|
519
|
219.00
|
10:52:57
|
00072183054TRLO0
|
XLON
|
|
1 November 2024
|
2318
|
218.00
|
11:00:54
|
00072183301TRLO0
|
XLON
|
|
1 November 2024
|
741
|
219.00
|
11:49:47
|
00072186039TRLO0
|
XLON
|
|
1 November 2024
|
450
|
219.00
|
11:49:47
|
00072186040TRLO0
|
XLON
|
|
1 November 2024
|
500
|
219.00
|
11:49:47
|
00072186041TRLO0
|
XLON
|
|
1 November 2024
|
4200
|
219.50
|
13:18:03
|
00072188768TRLO0
|
XLON
|
|
1 November 2024
|
2236
|
219.50
|
13:48:48
|
00072190407TRLO0
|
XLON
|
|
1 November 2024
|
2007
|
219.50
|
15:08:39
|
00072194489TRLO0
|
XLON
|
|
1 November 2024
|
1163
|
219.00
|
15:15:48
|
00072194934TRLO0
|
XLON
|
|
1 November 2024
|
450
|
220.50
|
15:39:57
|
00072196007TRLO0
|
XLON
|
|
1 November 2024
|
514
|
220.50
|
15:39:57
|
00072196008TRLO0
|
XLON
|
|
1 November 2024
|
2026
|
220.00
|
15:40:22
|
00072196028TRLO0
|
XLON
|
|
1 November 2024
|
1115
|
219.50
|
16:05:42
|
00072197208TRLO0
|
XLON
|
|
1 November 2024
|
939
|
219.50
|
16:05:42
|
00072197209TRLO0
|
XLON
|
|
1 November 2024
|
1194
|
219.50
|
16:05:42
|
00072197210TRLO0
|
XLON
|
|
1 November 2024
|
1430
|
220.00
|
16:09:37
|
00072197421TRLO0
|
XLON
|
This announcement will also be
available on the Company's website at:
https://investors.spirehealthcare.com/news/regulatory-news/
Enquiries:
Spire Healthcare
Harbant Samra,
CFO
+44 (0)7881 672 365
Instinctif Partners
Julian
Walker
+44 (0)7825 189 696
Registered Office and Head Office:
Spire Healthcare Group
plc
3 Dorset Rise
London
EC4Y 8EN
Registered number
09084066
About Spire Healthcare
Spire Healthcare
is a leading independent healthcare group in the
United Kingdom, running 38 hospitals and over 50 clinics, medical
centres and consulting rooms across England, Wales and Scotland. It
operates a network of private GPs and provides occupational health
services to over 800 corporate clients.
Working in partnership with over
8,600 experienced consultants, Spire Healthcare delivered tailored,
personalised care to over 1 million inpatients, outpatients and
daycase patients, and occupational health programme clients, in
2023, and is the leading private provider, by volume, of
knee and
hip operations in the United Kingdom.
It also delivers a range of private and NHS mental health,
musculoskeletal and dermatological services under the Vita Health
Group brand.
Spire Healthcare's well-located and
scalable hospitals have delivered successful and award-winning
outcomes, positioning the group well with patients, consultants,
the NHS, GPs and Private Medical Insurance ('PMI') providers. 98%
of Spire Healthcare's inspected locations are rated 'Good',
'Outstanding' or the equivalent by health inspectors in England,
Wales and Scotland.
Spire Healthcare is listed on the
London Stock Exchange and is a member of the FTSE 250.
